We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New System May Enable at-Home Testing for Sleep Disorders

By LabMedica International staff writers
Posted on 06 Oct 2015
Print article
Caption: Portrayal of the simple, noninvasive new system that tests for sleep disorders based on whole-night audio recordings for breath sound analysis (BSA)—far more convenient and lower cost than polysomnography (PSG), with potential to be performed at the patient’s home (Image courtesy of Ben Gurion University).
Caption: Portrayal of the simple, noninvasive new system that tests for sleep disorders based on whole-night audio recordings for breath sound analysis (BSA)—far more convenient and lower cost than polysomnography (PSG), with potential to be performed at the patient’s home (Image courtesy of Ben Gurion University).
Sleep analysis experts have developed a noninvasive system based on audio recordings for breath sound analysis (BSA) that may help simplify diagnosis of sleep disorders such as obstructive sleep apnea (OSA), at far more convenience and lower cost than polysomnography (PSG), resulting in increased willingness for patients to undergo testing.

"We’ve developed a non-contact, BSA algorithm that provides a reliable estimation of whole-night sleep evaluation for detection of sleep quality, snoring severity, and OSA. It has the potential to reduce the cost and management of sleep disorders,” said study leader Yaniv Zigel, PhD, Dept. Biomedical Engineering, Ben Gurion University (Be'er Sheva, Israel).

PSG requires a full night sleep-center stay and patients are connected to numerous electrodes and sensors to acquire signals and data from electroencephalography (EEG), electrooculography (EOG), electromyography (EMG), and electrocardiography (ECG) tests. The data is processed and visually examined or mathematically transformed manually in order to reveal insights about sleep/wake states and many aspects of physiology. “This procedure is time-consuming, tedious, and costly due to complexity and the need for technical expertise; the market is begging for a better solution,” said first author Eliran Dafna, BGU PhD student.

In the design and validation studies, whole-night breathing sounds were measured from 150 patients using both ambient microphones and PSG simultaneously. The system was trained in a design study on 80 subjects and a validation study was blindly performed on the additional 70 subjects. A set of acoustic features quantifying breathing patterns was developed to distinguish between sleep and wake segments. Sleep quality parameters were calculated based on the sleep/wake classifications and compared with PSG for validity.

When comparing sleep quality parameters, there were only minor average differences between PSG and BSA. Measuring 150,000 individual time segments (epochs), the BSA epoch-by-epoch accuracy rate for the validation study was 83.3% with 92.2% sensitivity measuring sleep-as-sleep, specificity of 56.6% for awake-as-awake, and Cohen's kappa of 0.508.

“The results showed that sleep/wake activity and sleep quality parameters can be reliably estimated solely using BSA,” said coauthor and sleep expert Prof. Ariel Tarasiuk, of BGU and Soroka University Medical Center (Be'er Sheva, Israel). “This study highlights the potential of this innovative approach to measure sleep in research and clinical circumstances. Clearly, the transition of this technology to at-home sleep evaluation depends on third-party reimbursements for the use of home-study equipment.”

The study, by Dafna E et al., was published February 24, 2015, in the journal PLOS ONE.

Related Links:

Ben Gurion University 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.